202 related articles for article (PubMed ID: 2086053)
1. [Modified radical mastectomy in the treatment of stage III breast carcinoma].
Sun M
Zhonghua Wai Ke Za Zhi; 1990 Oct; 28(10):607-9, 637. PubMed ID: 2086053
[TBL] [Abstract][Full Text] [Related]
2. [Modified radical mastectomy--an analysis of 217 cases].
Sun M
Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):291-3. PubMed ID: 2272265
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiation after modified radical mastectomy for breast cancer fails to prolong survival.
Geisler DP; Boyle MJ; Malnar KF; Melichar RM; McGee JM; Nolen MG; Broughan TA
Am Surg; 2000 May; 66(5):452-8; discussion 458-9. PubMed ID: 10824745
[TBL] [Abstract][Full Text] [Related]
5. [Surgical treatment of breast cancer in elderly women--analysis of 244 patients].
Zhan YQ; Li GC
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):149-51. PubMed ID: 3208657
[TBL] [Abstract][Full Text] [Related]
6. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
7. The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy.
Winchester DJ; Menck HR; Winchester DP
Cancer; 1997 Jul; 80(1):162-7. PubMed ID: 9210722
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of breast carcinoma. Our experience].
Sorice G; Fornaro R; Parodi G; Belcastro E
Ann Ital Chir; 1991; 62(5):437-41. PubMed ID: 1666275
[TBL] [Abstract][Full Text] [Related]
9. Treatment of carcinoma of the breast by modified radical mastectomy.
Papatestas AE; Lesnick GJ
Surg Gynecol Obstet; 1975 Jan; 140(1):22-6. PubMed ID: 1209469
[TBL] [Abstract][Full Text] [Related]
10. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
Poggi MM; Danforth DN; Sciuto LC; Smith SL; Steinberg SM; Liewehr DJ; Menard C; Lippman ME; Lichter AS; Altemus RM
Cancer; 2003 Aug; 98(4):697-702. PubMed ID: 12910512
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of male breast cancer: an analysis of 41 cases].
Yang MT
Zhonghua Wai Ke Za Zhi; 1993 May; 31(5):290-2. PubMed ID: 8112159
[TBL] [Abstract][Full Text] [Related]
12. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.
Yu KD; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
Ann Surg Oncol; 2007 Sep; 14(9):2502-9. PubMed ID: 17564750
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
16. [The extent of the surgical intervention and the prognosis of patients with stage III breast cancer].
Adamian AT; Slonimskaia EM; Pushkarev SV
Vopr Onkol; 1989; 35(6):699-703. PubMed ID: 2750083
[TBL] [Abstract][Full Text] [Related]
17. Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer.
Noguchi M; Yagasaki R; Kawahara F; Minami M; Tsuyama H; Earashi M; Kinoshita K; Taniya T; Miwa K; Nishijima H; Takanaka T; Kawashima H; Takashima C; Kanno M; Nakamura S; Mizukami Y; Nonomura A; Michigishi T; Yokoyama K
Int Surg; 1997; 82(3):289-94. PubMed ID: 9372377
[TBL] [Abstract][Full Text] [Related]
18. [Treatment selection for stage I breast cancer--report of 412 cases].
Zhou P
Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):471-3. PubMed ID: 2634551
[TBL] [Abstract][Full Text] [Related]
19. Is mastectomy superior to breast-conserving treatment for young women?
Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
